SCHEMBL3601792

SCHEMBL3601792

CN(C(=O)O)c1cc(-c2cccnc2)n[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.56
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.49
CYP2A6 P11509 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2B6 P20813 1/20 0.49
CYP2C19 P33261 1/20 0.49
METAP2 P50579 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
HPGDS O60760 1/20 0.45
PDE10A Q9Y233 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816813 0.75 TP53 (0.73) ALKALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL28764408 0.72 KMO (0.56) ALDH1A1CYP1A2CYP3A4CYP2A6PIM1
SCHEMBL1436058 0.72 ALK (1.00) ALKALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3606930 0.72 CYP2A6 (0.49) ALKALDH1A1CYP2A6CYP2C9CYP2B6
SCHEMBL16671557 0.72 ALK (0.40) ALKALDH1A1CYP1A2CYP3A4CYP2A6
SCHEMBL4853168 0.71 ALDH1A1 (0.58) ALKALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL22191641 0.71 CYP2D6 (0.67) ALKALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL2851890 0.71 ALDH1A1 (0.61) ALKALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL3078162 0.71 CYP3A4 (0.89) ALKALDH1A1CYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL22320090 0.70 CYP2D6 (0.65) ALKALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609708-B2 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2013-12-17 US disclosed
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2010-11-25 US disclosed
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2008-08-07 US disclosed
WO-2005066162-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188527-A1 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer CYP2A13, CYP2A6, CYP2B6 ALK 3085/4885ALDH1A1 762/4885CYP1A2 19/4885
US-20100298345-A1 SYNTHETIC COMPOUNDS AND DERIVATIVES AS MODULATORS OF SMOKING OR NICOTINE INGESTION AND LUNG CANCER CYP2A13, CYP2A6, CYP2B6 ALK 3085/4885ALDH1A1 762/4885CYP1A2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.